Quick answers
- What is Hetlioz LQ?
- Hetlioz LQ is a brand name of Tasimelteon, a prescription medicine. The FDA NDC Directory lists 1 Hetlioz LQ product in 1 strength and form.
- Who makes Hetlioz LQ?
- Vanda Pharms Inc holds the FDA application for Hetlioz LQ (NDA214517, approved December 1, 2020).
- Is there a generic or store brand of Hetlioz LQ?
- Other products of Tasimelteon are listed with the FDA, but none in exactly the same strength and form as a Hetlioz LQ product.
- Has Hetlioz LQ been recalled?
- No recall linked to Hetlioz LQ products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Hetlioz LQ is
Each Hetlioz LQ product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Tasimelteon · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| tasimelteon 4 mg/mL suspension (oral) | Hetlioz LQ | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tasimelteon →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA214517 | Vanda Pharms Inc | December 1, 2020 | 1 |
Companies that list Hetlioz LQ
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Hetlioz LQ products.
- Vanda Pharmaceuticals Inc.1 product
Recalls
No recall linked to Hetlioz LQ products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.